FDA Inspection 1324954 — Virbac Corporation
The FDA completed an inspection of Virbac Corporation on June 3, 2026 in Bridgeton, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 3, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Bridgeton, MO (United States)